Last updated on July 2019

A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis

Brief description of study

This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sclerosis (PMS).

Clinical Study Identifier: NCT03523858

Find a site near you

Start Over